NCT03310437

Brief Summary

Cost effectiveness between PPCI and thrombolytic therapy in STEMI patients without contraindications

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2017

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 16, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

February 7, 2018

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

July 5, 2019

Status Verified

July 1, 2019

Enrollment Period

2.1 years

First QC Date

September 25, 2017

Last Update Submit

July 1, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compare between PPCI and thrombolytic therapy regarding over all cost in STEMI patients

    we will compare different outcomes in ST elevation myocardial infarction patients presented to our hospital who had recieved intervention (primary PCI ) versus thrombolytic as regarded in all over cost in egyptian pounds and follow up for 6 month

    one year for collecting 100 patient for each arm with follow up 6 month

Study Arms (2)

Primary PCI

In primary PCI we use arterial sheath , wires ,heparin ,intracoronary stents

Procedure: Primary PCI

Thrombolytic

In patients recieving thrombolytics they continue on LWMH for 72h ,plus aspirin , clopedogril , BB, statins

Interventions

Primary PCIPROCEDURE

Primary percutaneous coronary intervention in acute myocardial infarction patients

Primary PCI

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients presented by ST elevation myocardial infarction

You may qualify if:

  • All PPCI patients within 90 minutes door to ballon.
  • All thrombolytic patient without contraindication ,within 6 golden hours of chest pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut medicine faculty

Asyut, Egypt

RECRUITING

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

September 25, 2017

First Posted

October 16, 2017

Study Start

February 7, 2018

Primary Completion

April 1, 2020

Study Completion

October 1, 2020

Last Updated

July 5, 2019

Record last verified: 2019-07

Locations